Skip to content
Search

Latest Stories

NHSE launches training programme to expand community pharmacy roles

The NHS England has introduced a training programme for 1000 staff to broaden their community pharmacy roles, thereby improving patient access to services. Among them, 500 pharmacy staff will be trained to supervise pharmacists during prescription training, while the remaining 500 will provide support for various training, including pre and post-registration programmes for pharmacists and pharmacy technicians.

According to the NHSE, pharmacist and pharmacy technician roles are rapidly evolving due to healthcare changes and increased demand for clinical services in community pharmacy. “There are 3,000 independent prescribing training spots available for 2023/24. Educational supervision is a crucial part of this to enable the ongoing transformation and skills development of the growing pharmacy workforce.”


The NHSE-funded training, scheduled to begin next month, will ensure that those involved in educational supervision, including Designated Supervisors (DSs), Pre-registration Trainee Pharmacy Technician education supervisors and Designated Prescribing Practitioners (DPPs), can effectively support learners.

The NHSE said that both pharmacists and pharmacy technicians are eligible to apply for education supervisor training. "Regulatory changes in 2019 expanded the opportunity for any experienced independent prescriber to seek DPP training."

The training will flexibly accommodate work schedules, enabling learners to enhance their skills and knowledge in providing educational supervision, all while prioritising patient safety and person-centred care, the NHSE added. The implementation of the programme will be conducted by ProPharmace Ltd, under the coordination of the Pharmacy Integration Programme at NHS England.

"This aligns with NHS England's strategy to enhance access to prescribing supervision in community pharmacy," said David Webb, Chief Pharmaceutical Officer at NHSE. "Our goal is to foster a culture in which current pharmacist independent prescribers transition into Designated Prescribing Practitioners and Designated Supervisors as part of their career progression. This effort forms part of our overarching work to prepare the NHS to mentor and support the incoming wave of pharmacist independent prescribers starting in 2026."

"Leveraging their expertise, Education Supervisors will facilitate the training of a greater number of pre and post-registration Pharmacy Technicians, nurturing their clinical responsibilities and services, thereby reinforcing reforms and ensuring sustainability for the future,” said Liz Fidler, Senior Professional Advisor for Pharmacy Technician Practice at NHSE.

“These programmes will provide an innovative approach to developing Educational Supervisors and Designated Prescribing Practitioners, considering individual learning needs and career aspirations,” said Noma Al-Ahmad, Managing Director, ProPharmace. "We eagerly look forward to aiding NHS England in achieving superior supervision standards as a central priority for transforming and enhancing the community pharmacy workforce."

For registration and further details regarding the training program, including eligibility criteria, visit the ProPharmace website.

More information about the Pharmacy Integration Programme and training opportunities for pharmacy professionals can be found on the Health Education England website.

Meanwhile, the NHS is expanding its blood pressure screening services to diverse local sites, such as barbershops, mosques, and pharmacies, to tackle the rising risk of strokes and heart attacks in men.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less